Oculis Holding AG

Healthcare · Biotechnology

9.10$ +0.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Oculis Holding AG (OCS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 250 million CHF. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of CHF.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OCS
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	129	114	99	139	126	120	204	182	168	236	243	250
Current Assets	115	101	85	125	111	105	189	166	151	219	226	233
Cash	31	38	24	44	36	28	60	64	46	81	64	0.0
Cash & Short-Term Investments	107	92	80	118	105	99	182	160	46	213	221	0.0
Receivables	2.2	8.0	1.3	2.3	1.8	0.8	2.6	2.4	–	1.0	1.6	1.8
Inventory	-2.2	-1.2	-1.3	2.0	–	–	–	–	–	–	–	–
Intangible Assets	12	12	12	12	12	13	13	13	13	13	13	13
Total Liabilities	23	21	20	26	30	47	42	39	37	40	47	31
Current Liabilities	22	19	18	24	28	44	39	37	34	37	44	28
Short-Term Debt	0.2	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.4	0.8
Accounts Payable	6.7	7.6	1.2	3.2	4.9	5.9	4.4	1.2	1.2	1.8	4.5	2.7
Shareholders' Equity	106	94	79	113	95	73	163	143	131	196	196	219
Retained Earnings	-187	-200	-216	-237	-257	-286	-319	-344	-361	-385	-412	-423
Shares Outstanding	36	37	37	41	42	42	48	52	53	56	59	61

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings